A human volunteer study to determine the prebiotic effects of lactulose powder on human colonic microbiota

Microbial Ecology in Health and Disease

Volumn 14, Issue 3, 2002, Pages 165-173

  Tuohy, Kieran M ^a   Ziemer, Cherie J ^a   Klinder, Annett ^a   Knöbel, Yvonne ^a   Pool Zobel, Beatrice L ^a   Gibson, Glenn R ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Faecal water biomarker; Gene probes; Gut microbiota; Lactulose; Prebiotic

Indexed keywords

BIOLOGICAL MARKER; DUPHALAC DRY; LACTULOSE; PROBIOTIC AGENT;

ABDOMINAL PAIN; ADULT; ARTICLE; BIFIDOBACTERIUM; CARBOHYDRATE DIET; CLINICAL TRIAL; CLOSTRIDIUM; COLON FLORA; COMET ASSAY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA DAMAGE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FLATULENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GASTROINTESTINAL SYMPTOM; GENE PROBE; GENOTOXICITY; HUMAN; LACTOBACILLUS; MICROBIAL METABOLISM; NORMAL HUMAN; POWDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; CLOSTRIDIA; CLOSTRIDIUM; LACTOBACILLUS; MICROBIOTA;

EID: 0036759065     PISSN: 0891060X     EISSN: None     Source Type: Journal    
DOI: 10.1080/089106002320644357     Document Type: Article

References (42)

1. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J Nutr 1995; 125: 1401-12.
2. Macfarlane GT, Gibson GR. Carbohydrate fermentation, energy transduction and gas metabolism in the human large intestine. In: Mackie RI, White BH, eds. Gastrointestinal Microbiology. London: Chapman & Hall, 1997: 269-318.
3. Gibson GR, Wang X. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 1994; 77: 412-20.
4. Hudault S, Liévin V, Bernet-Camard M-F, Senin AL. Antogonistic activity exerted in vitro and in vivo by Lactobacillus casei (Strain GG) against Salmonella typhimurium C5 infection. Appl Environ Microbiol 1997; 63: 513-8.
5. Jacobsen CN, Rosenfeldt Nielsen V, Hayford AE, Moller PL, Michaelsen KF, Pærregaard A, Sandström B, Tvede M, Jakobsen M. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. By in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol 1999; 65: 4949-56.
6. Liévin, V, Peiffer I, Hudault S, Rochat F, Brassart D, Neeser J-R, Servin AL. Bifidobacterium strains from resident infant human gastrointestinal microbiota exert antimicrobial activity. Gut 2000; 47: 646-52.
7. McCracken VJ, Gaskins HR. Probiotics and the immune system. In: Tannock GW, ed. Probiotics A Critical Review. Wymondham: Horizon Scientific Press, 1999: 85-111.
8. Tuomola EM, Ouwehand AC, Salminen SJ. The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus. FEMS Immunol Med Microbiol 1999; 26: 137-42.
9. Forestier C, De Champs C, Vatoux C, Joly B. Probiotic activities of Lactobacillus casei rhamnosus: In vitro adherence to intestinal cells and antimicrobial properties. Res Microbiol 2001; 152: 167-73.
10. Conway PL. Microbial ecology of the human large intestine. In: Gibson GR, Macfarlane GT, eds. Human Colonic Bacteria: Role in Nutrition, Physiology and Pathology. Boca Raton: CRC Press, 1995: 1-24.
11. Roberfroid MB, Bornet F, Bouley C, Cummings JH. Colonic microbiota: Nutrition and health Nutr Revs 1995; 53: 127-30.
12. Tannock GW. A fresh look at the intestinal microbiota. In: Tannock GW, ed. Probiotics a Critical Review. Wymondham: Horizon Scientific Press, 1999: 5-14.
13. Steer T, Carpenter H, Tuohy K, Gibson GR. Perspectives on the role of the human gut microbiota in health and disease and its modulation by pro- and prebiotics. Nutr Res Revs 2000; 13: 229-54.
14. Gibson GR, Berry-Ottaway P, Rastall RA. Prebiotics: New Developments in Functional Foods. Oxford, UK: Chandos Publishing Limited, 2000.
15. Salminen S, Salminen E. Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection. Scand J Gastroenterol 1997; 32 (Suppl 222): 45-8.
16. Clausen MR, Mortensen PB. Lactulose, disaccharides and colonic flora. Drugs 53; 930-942.
17. Cummings JH, Bingham SA, Heaton KW, Eastwood MA. Fecal weight, colon cancer risk, and dietary intake of nonstarch polysaccharides (dietary fiber). Gastroenterol 1992; 103: 1783-9.
18. Terada A, Hara H, Kataoka M, Mitsuoka T. Effect of lactulose on the composition and metabolic activity of the human faecal microbiota. Microb Ecol Health Dis 1992; 5: 43-50.
19. Ballongue J, Schumann C, Quignon P. Effects of lactulose and lactitol on colonic microbiota and enzymatic activity. Scand J Gastroenterol 1997; 32: 41-4.
20. Hirayama K, Rafter J. The role of lactic acid bacteria in colon cancer prevention: Mechanistic considerations. Ant Van Leeuwenhoek 1999; 76: 391-4.
21. Bolognani F, Rumney CJ, Rowland IR. Influence of carcinogen binding by lactic acid-producing bacteria on tissue distribution and in vivo mutagenicity of dietary carcinogens. Food Chem Toxicol 1997; 35: 535-45.
22. Langendijk PS, Schut F, Jansen GJ, Raangs GW, Kamphuis GR, Wilkinson MHF, Welling GW. Quantitative fluorescent in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in faecal samples. Appl Environ Microbiol 1995; 61: 3069-75.
23. Hartemink R, Rombouts FM. Comparison of media for the detection of bifidobacteria, lactobacilli and total anaerobes from faecal samples. J Microbiol Methods 1999; 36: 181-92.
24. Wilson KH, Blitchington RB. Human colonic bacteria studied by ribosomal DNA sequence analysis. Appl Environ Microbiol 1996; 62: 2273-8.
25. Suau A, Bonnet R, Sutren M, Godon J-J, Gibson GR, Collins MD, Doré J. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 1999; 65: 4799-807.
26. Beerens H. An elective and selective isolation medium for Bifidobacterium spp. Letts Appl Microbiol 1990; 11: 155-7.
27. Silvi S, Rumney CJ, Rowland IR. An assessment of three selective media for bifidobacteria in faeces. J Appl Bacteriol 1996; 81: 561-4.
28. Hartemink R, Kok BJ, Weenk GH, Rombouts FM. Raffinose-Bifidobacterium (RB) agar, a new selective medium for bifidobacteria. J Microbiol Methods 1996; 27: 33-43.
29. Manz W, Amann R, Ludwig W, Vancanneyt M, Schleifer K-H. Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment. Microbiol 1996; 142: 1097-106.
30. Franks AH, Harmsen HJM, Raangs GC, Jansen GJ, Schut F, Welling GW. Variations of bacterial populations in human faeces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 1998; 64: 3336-45.
31. Harmsen HJM, Elfferich P, Schut F, Welling GW. A 16S rRNA-targeted probe for detection of lactobacilli and enterococci in faecal samples by fluorescent in situ hybridization. Microb Ecol Health Dis 1999a; 11: 3-12.
32. Porter KG, Feig YS. The use of DAPI for identifying and counting aquatic microbiota. Limnol Oceanog 1980; 25: 943-8.
33. Harmsen HJM, Gibson GR, Elfferich P, Raangs GC, Wideboer-Veloo ACM, Argaiz A, Roberfroid MB, Welling GW. Comparison of viable cell counts and fluorescent in situ hybridization using specific rRNA-based probes for the quantification of human faecal bacteria. FEMS Microb Ecol 1999b; 183: 125-9.
34. Tuohy KM, Finlay RK, Wynne AG, Gibson GR. A human volunteer study on the prebiotic effects of HP-inulin - Faecal bacteria enumerated using fluorescent in situ hybridization (FISH). Anaerobe 2001a; 7: 113-8.
35. Osswald K, Becker TW, Grimm M, Jahreis G, Pool-Zobel BL. Inter- and intra-individual variation of faecal water-genotoxicity in human colon cells. Mutat Res 2000; 472: 59-70.
36. Augeron C, Laboisse CL. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res 1984; 44: 3961-9.
37. Pool-Zobel BL, Abrahamse SL, Collins AR, Kark W, Gugler R, Oberreuther D, Siegel EG, Treptow-van Lishaut S, Rechkemmer G. Analysis of DNA strand breaks, oxidized bases and glutathione S-transferase P1 in human colon cells. Cancer Epidemiol Biomark Prev 1999; 8: 609-14.
38. Rowland IR. Toxicology of the colon: Role of the intestinal microbiota. In: Gibson GR, Macfarlane GT, eds. Human Colonic Bacteria: Role in Nutrition, Physiology and Pathology. Boca Raton: CRC Press, 1995: 155-74.
39. Pool-Zobel BL, Neudecker C, Domizlaff I, Ji S, Schillinger U, Rumney C, Moretti M, Vilarini I, Scassellati-Sforzolini R, Rowland I. Lactobacillus- and Bifidobacterium-mediated antigenotoxicity in the colon of rats. Nutr Cancer 1996; 26: 365-80.
40. Tuohy KM, Kolida S, Lustenberger AM, Gibson GR. The prebiotic effects of biscuits containing partially hydrolyzed guar gum and fructo-oligosaccharides - A human volunteer study. Brit J Nutr 2001b; 86: 341-8.
41. Roberfroid MB, Van Loo JAE, Gibson GR. The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr 1998; 128: 11-9.
42. Harmsen HJM, Raangs GC, He T, Degener JE, Welling GW. Extensive set of 16S rRNA-based probes for detection of bacteria in human feces. Appl Environ Microbiol 2002; 68: 2982-90.